![IJMS | Free Full-Text | The Signaling Role of CD40 Ligand in Platelet Biology and in Platelet Component Transfusion IJMS | Free Full-Text | The Signaling Role of CD40 Ligand in Platelet Biology and in Platelet Component Transfusion](https://www.mdpi.com/ijms/ijms-15-22342/article_deploy/html/images/ijms-15-22342-g003.png)
IJMS | Free Full-Text | The Signaling Role of CD40 Ligand in Platelet Biology and in Platelet Component Transfusion
![BLYS, CD40, CD86, and CD40L genotypes in relation to antibody titers... | Download Scientific Diagram BLYS, CD40, CD86, and CD40L genotypes in relation to antibody titers... | Download Scientific Diagram](https://www.researchgate.net/publication/295682170/figure/fig1/AS:340751650181158@1458252932748/BLYS-CD40-CD86-and-CD40L-genotypes-in-relation-to-antibody-titers-against-the.png)
BLYS, CD40, CD86, and CD40L genotypes in relation to antibody titers... | Download Scientific Diagram
![CD40L (human) (multimeric) (recombinant protein) - AdipoGen Life Sciences - B cell Activation and Expansion - T cell activation - Anti-tumor immunity CD40L (human) (multimeric) (recombinant protein) - AdipoGen Life Sciences - B cell Activation and Expansion - T cell activation - Anti-tumor immunity](https://adipogen.com/pub/media/catalog/product/m/u/multimeric_cd40lweb2.png)
CD40L (human) (multimeric) (recombinant protein) - AdipoGen Life Sciences - B cell Activation and Expansion - T cell activation - Anti-tumor immunity
![Controlled Modular Multivalent Presentation of the CD40 Ligand on P22 Virus-like Particles Leads to Tunable Amplification of CD40 Signaling | ACS Applied Bio Materials Controlled Modular Multivalent Presentation of the CD40 Ligand on P22 Virus-like Particles Leads to Tunable Amplification of CD40 Signaling | ACS Applied Bio Materials](https://pubs.acs.org/cms/10.1021/acsabm.1c00718/asset/images/medium/mt1c00718_0002.gif)
Controlled Modular Multivalent Presentation of the CD40 Ligand on P22 Virus-like Particles Leads to Tunable Amplification of CD40 Signaling | ACS Applied Bio Materials
![IJMS | Free Full-Text | Simultaneous Inhibition of PD-1 and Stimulation of CD40 Signaling Pathways by Anti-PD-L1/CD40L Bispecific Fusion Protein Synergistically Activate Target and Effector Cells IJMS | Free Full-Text | Simultaneous Inhibition of PD-1 and Stimulation of CD40 Signaling Pathways by Anti-PD-L1/CD40L Bispecific Fusion Protein Synergistically Activate Target and Effector Cells](https://www.mdpi.com/ijms/ijms-22-11302/article_deploy/html/images/ijms-22-11302-g001.png)
IJMS | Free Full-Text | Simultaneous Inhibition of PD-1 and Stimulation of CD40 Signaling Pathways by Anti-PD-L1/CD40L Bispecific Fusion Protein Synergistically Activate Target and Effector Cells
![CD40L-expressing CD4+ T cells prime adipose-derived stromal cells to produce inflammatory chemokines - Cytotherapy CD40L-expressing CD4+ T cells prime adipose-derived stromal cells to produce inflammatory chemokines - Cytotherapy](https://www.isct-cytotherapy.org/cms/attachment/5740fae7-9337-4865-926e-2637cb938883/ga1_lrg.jpg)
CD40L-expressing CD4+ T cells prime adipose-derived stromal cells to produce inflammatory chemokines - Cytotherapy
![CD40L Deficiency Protects Against Aneurysm Formation | Arteriosclerosis, Thrombosis, and Vascular Biology CD40L Deficiency Protects Against Aneurysm Formation | Arteriosclerosis, Thrombosis, and Vascular Biology](https://www.ahajournals.org/cms/asset/d0557faa-c6fe-4dc8-8cb0-7a2b6982510c/16ga01.jpg)
CD40L Deficiency Protects Against Aneurysm Formation | Arteriosclerosis, Thrombosis, and Vascular Biology
![IJMS | Free Full-Text | CD40/CD40L and Related Signaling Pathways in Cardiovascular Health and Disease—The Pros and Cons for Cardioprotection IJMS | Free Full-Text | CD40/CD40L and Related Signaling Pathways in Cardiovascular Health and Disease—The Pros and Cons for Cardioprotection](https://pub.mdpi-res.com/ijms/ijms-21-08533/article_deploy/html/images/ijms-21-08533-ag.png?1607087365)
IJMS | Free Full-Text | CD40/CD40L and Related Signaling Pathways in Cardiovascular Health and Disease—The Pros and Cons for Cardioprotection
![Frontiers | Double Strike Approach for Tumor Attack: Engineering T Cells Using a CD40L:CD28 Chimeric Co-Stimulatory Switch Protein for Enhanced Tumor Targeting in Adoptive Cell Therapy Frontiers | Double Strike Approach for Tumor Attack: Engineering T Cells Using a CD40L:CD28 Chimeric Co-Stimulatory Switch Protein for Enhanced Tumor Targeting in Adoptive Cell Therapy](https://www.frontiersin.org/files/Articles/750478/fimmu-12-750478-HTML/image_m/fimmu-12-750478-g001.jpg)